Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which gives an overview of the antibacterial market, and forecasts that it will reach US$45.0 billion in the next five years.

"The Global Antibacterials Market - R&D Pipelines, Market Analysis and Competitive Landscape" finds that the global anti-infective market is currently valued at US$66.5 billion with antibacterial agents accounting for over 50% of sales. It says the market for antibacterials will expand due to the uptake of newer antibacterial agents such as glycopeptides and carbapenems which demonstrate resistance to methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) as well as other emerging strains.

Authors of the report say that pharmaceutical companies will persist in developing a new generation of antibacterial agents such as cephalosporins, macrolides and quinolones to overcome the major issue of drug resistance. They point out that a number of new drug classes such as dihydrofolate reductase inhibitors (DHFR) are under evaluation which are effective in multi drug resistant organisms.

This report examines each of the antibacterial classes, assessing their market potential and application in hospital and community-acquired infections. It assesses the overall antibacterial market, key classes and the drivers and resistors influencing their prescription.

The study also examines promising pipeline products and their potential impact on the prescription of current and new antibacterial agents and the future of the antibacterial market. It outlines future trends in the antibacterial marketplace, driven by drug resistance and patient demographics.

"The Global Antibacterials Market- R&D Pipelines, Market Analysis and Competitive Landscape" is available in pdf format from Piribo. For more information, go to:
http://www.piribo.com/publications/treatments/global_antibacterials_market.html

Piribo product ID: ARR025

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.